Press Release Source: eGene, Inc. QIAGEN Signs Agreement for the Acquisition of eGene Friday April 13, 10:40 am ET Strategic Transaction Adds Capillary Sample Separation Technology VENLO, The Netherlands–QIAGEN N.V. (Nasdaq:QGEN – News; Frankfurt, Prime Standard:QIA), the world’s leading provider of sample and assay technologies for research in life sciences, applied testing and molecular diagnostics, […]
SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE:A – News) today announced that it has signed a definitive agreement with Stratagene Corp. (NASDAQ:STGN – News) to acquire the developer, manufacturer and marketer of specialized life science research and diagnostic products. Under the terms of the agreement, each share of Stratagene common stock will be converted into the […]
Roche and CuraGen today announced that they have signed a definitive agreement under which Roche will acquire 100% of 454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, active in high-throughput DNA sequencing. Under the terms of the agreement, Roche will pay 454 Life Sciences’ shareholders USD 140 million in cash. In addition to the […]
DUSSELDORF, Germany, March 20 — Gerresheimer has agreed with the US company Thermo Fisher Scientific Inc. (TMO) to establish a joint venture company under the name “Kimble/Chase Life Scienceware LLC”. The company will be based in New Jersey/USA. Gerresheimer contributes its life-science business to the new company in parallel with certain laboratory glass-ware product lines […]
NEW YORK, Feb. 13 — Avista Capital Partners, a leading private equity firm, announced today it has signed a definitive agreement to acquire BioReliance Corporation, a business unit of Invitrogen Corporation (Nasdaq: IVGN – News) for approximately $210 million. BioReliance is a leading contract service organization providing biological safety testing, toxicology, viral manufacturing, and laboratory […]
Aequorin Technology Would Strengthen Leadership Position in GPCR Screening BOSTON–PerkinElmer, Inc. (NYSE: PKI – News), a global technology leader in Health Sciences and Photonics, today announced it signed an agreement with Euroscreen S.A., entitling it to acquire Euroscreen S.A.’s majority owned subsidiary, Euroscreen Products S.A., in a cash transaction. Based in Gosselies, Belgium, Euroscreen Products […]
November 17, 2006, IJsselstein/Hyderabad – Ocimum Biosolutions, a leading provider of laboratory information management systems (LIMS), bioinformatics solutions, Microarrays and contract research headquartered in Hyderabad, India, has acquired the BioMolecules synthesis business of Isogen Life Science based in The Netherlands. Ms. Anuradha Acharya, CEO of Ocimum Biosolutions said “We are very pleased to have taken […]
SAN DIEGO & HAYWARD, Calif.–Illumina, Inc. (NASDAQ: ILMN – News) and Solexa, Inc. (NASDAQ: SLXA – News) announced today that they have entered into a definitive merger agreement under which Illumina will acquire Solexa in a stock-for-stock merger. Under the merger agreement, which was unanimously approved by the Boards of Directors of both companies, Solexa’s […]
VENLO, The Netherlands, October 30, 2006 – QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA), a leading provider of molecular diagnostics products and the world’s premier supplier of solutions for preanalytical sample preparation, today announced that it acquired all outstanding shares of Genaco Biomedical Products, Inc. (Genaco). Genaco is an early-stage company applying a proprietary […]
EAST RUTHERFORD, N.J., Oct. 24 — Cambrex Corporation (“Cambrex”) (NYSE: CBM) today announced that it has entered into a definitive stock purchase agreement with Lonza Group AG (“Lonza”) (SWX: LONN) for the sale of the businesses that comprise its Bioproducts and Biopharma segments (“Bio Businesses”), for total cash consideration of $460 million. The Company expects […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
